Brand: crb
Features:
- Bioinformatics Analyse:Raw data as FASTQ files, variant calling, customizable data analysis report etc.
- Potential Application:Cancer biomarker discovery,Cancer mechanism study.
- Gene fusion/mutation detection
- Design genetic tests, such as for pharmacogenomics or oncology
- Cancer therapeutic target discovery
crb
Details:
* Chromosomal translocations in the human leukemias rearrange the regulatory and coding regions of a variety of transcription factor genes.
* The resultant protein products can interfere with regulatory cascades that control the growth, differentiation, and survival of normal blood cell precursors.
* Many of these genetic alterations have important prognostic implications that can guide the selection of therapy.
* Crb's Leukemia RNA Panel Sequencing Service screens for common leukemia translocations in addition to point mutations, small insertions, or deletions in cancer genome.
* Designed and verified to provide thorough coverage and assessment on specific cancers of interest.
* Discover common and rare genetic mutations including point mutations and low-frequency aberrations.
* Extensive multiplexing flexibility enables a more cost-effective assay.
* Ultra-deep sequencing of targeted regions to detects rare mutations.
* Comprehensive bioinformatics options for robust downstream analysis.
* Fast turnaround time.
*Paired-end sequence data from the most cutting-edge sequencing platforms.
*Dedicated, on-going support from experienced Crb scientists.
